Amarin Corp Plc (AMRN)

[couldbebetter]

Jeffkad, "Bingo." Keep in mind that at some point AMRN may also
have the replacement for Vascepa which Mochida is testing
which I think is a one a day version which does not need
to be taken with fat. In the unlikely event AMRN loses
to the generics, maybe AMRN would roll out the Mochida
version earlier than planned (assuming that is even possible)
and only roll it out in Europe when it loses exclusivity.